Equity
€40,689 ▼ 19.2%
DENTALEX paid out €38,443 in dividends. That is 134% of the 2025 profit.
DENTALEX
Lifetime
17 annual accounts with figures on one time axispeak €166,706 (2024)
€140,550▼ 15.7%
lowest -€60,541 (2022)
€28,765▼ 35.1%
peak €64,735 (2021)
€40,689▼ 19.2%
€225,764▲ 3.1%
peak 2 FTE (2009)
-not published
Board3 names since 2022
3 directors and 2 others
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Gross margin from €166,706 to €140,550Result from €44,300 to €28,765Dividend €38,443Equity from €50,368 to €40,689Cash from €2,099 to €3,933
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 5,053 companies had the same profile as DENTALEX has now. Each dot stands for 13 companies, two years later.
95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,053 companies, not a prediction for DENTALEX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0895296637
2 directors appointed, 1 manager resigning, 1 reappointment
Resignation: (manager) · Reappointment: (director) · Appointments: (director) and (director) · General meeting of 11-02-2022 · Gazette deed
Incorporation
published on 07-02-2008 · Gazette deed
First establishment
Veldlei 58, Schilde
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DENTALEX Schilde | €266,453 | €140,550 | 15.3% | - |
| Care4Excellence Overijse | €307,250 | €131,173 | 44.2% | - |
| EXEL DENTAL Braine-le-Comte | €383,704 | €145,877 | 24.4% | - |
| Brussels Medical Center Oostkamp | €272,306 | €237,889 | 5.8% | 4.3 |
| Orca Consulting Kapellen | €347,741 | €71,787 | 68.8% | - |
| PHARMA 2424 Charleroi | €550,405 | €195,539 | 55.3% | 1.1 |
| DCVISION Kaprijke | €443,302 | €158,650 | 47.6% | - |
These companies have the same main activity as DENTALEX: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €272,000 and €550,000, founded between 2000 and 2015.
Official details
Source: KBO- Status
- Active since 18-01-2008Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 1 other
- Establishment unit
- 2.168.985.4252970 Schilde, since 18-01-2008
- Financial year end
- 30 June
- Peppol
- Reachable since 20-11-2025
Annual accounts to 30-06-2025
- ≈ €350,000estimated
- €266,453▼ 1.1%
- Employeeson 30-06-2025
- 2=
- Filing
- Filed on 30-01-2026, 1 day before the end of the filing period
Insights on DENTALEX
DENTALEX files the micro format. That format states no turnover. The gross margin fell from €148,428 in 2009 to €140,550 in 2025.
The balance sheet grew most in 2022 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DENTALEX
- What is the company number of DENTALEX?
- The company number of DENTALEX is 0895.296.637. The VAT number is the same number with BE in front: BE 0895.296.637.
- Where is DENTALEX based?
- The registered office is at Veldlei 53, 2970 Schilde.Company details
- What does DENTALEX do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
- What is the legal form of DENTALEX?
- DENTALEX is a private limited company (BV).
- When was DENTALEX founded?
- DENTALEX was founded on 18-01-2008.
- Is DENTALEX still active?
- Yes, DENTALEX is an active enterprise in the KBO register.
- How many employees does DENTALEX have?
- DENTALEX had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of DENTALEX?
- The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €140,550 and 2,204 comparable companies of the same size. It probably lies between €230,000 and €540,000. It is a rough estimate.
- Is DENTALEX profitable?
- In financial year 2025, DENTALEX made a profit of €28,765.
- Where can I find the annual accounts of DENTALEX?
- DENTALEX filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DENTALEX due?
- DENTALEX must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.